Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children

References

• Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol. 2012;87:795–803. doi: 10.1002/ajh.23232
   PubMed Web of Science ®Google Scholar
• Nur E, Biemond BJ, Otten HM, et al. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am J Hematol. 2011;86:484–489. doi: 10.1002/ajh.22012
   PubMed Web of Science ®Google Scholar
• Silva DG, Belini Junior E, de Almeida EA, et al. Oxidative stress in sickle cell disease: an overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies. Free Radic Biol Med. 2013;65:1101–1109. doi: 10.1016/j.freeradbiomed.2013.08.181
   PubMed Web of Science ®Google Scholar
• Barabino GA, Platt MO, Kaul DK. Sickle cell biomechanics. Annu Rev Biomed Eng. 2010;12:345–367. doi: 10.1146/annurev-bioeng-070909-105339
   PubMed Web of Science ®Google Scholar
• Banerjee T, Kuypers FA. Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol. 2004;124:391–402. doi: 10.1046/j.1365-2141.2003.04781.x
   PubMed Web of Science ®Google Scholar
• Hebbel RP, Morgan WT, Eaton JW, et al. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci USA. 1988;85:237–241. doi: 10.1073/pnas.85.1.237
   PubMed Web of Science ®Google Scholar
• Akohoue SA, Shankar S, Milne GL, et al. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res. 2007;61:233–238. doi: 10.1203/pdr.0b013e31802d7754
   PubMed Web of Science ®Google Scholar
• Al-Naama LM, Hassan MK, Mehdi JK. Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia. Qatar Med J. 2015;2015:14. doi: 10.5339/qmj.2015.14
   PubMedGoogle Scholar
• Klings ES, Farber HW. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res. 2001;2:280–285. doi: 10.1186/rr70
   PubMed Web of Science ®Google Scholar
• Voskou S, Aslan M, Fanis P, et al. Oxidative stress in β-thalassaemia and sickle cell disease. Redox Biol. 2015;6:226–239. doi: 10.1016/j.redox.2015.07.018
   PubMed Web of Science ®Google Scholar
• Perrone S, Tataranno ML, Stazzoni G, et al. Oxidative injury in neonatal erythrocytes. J Matern Fetal Neonatal Med. 2012;25:104–108. doi: 10.3109/14767058.2012.715471
   PubMed Web of Science ®Google Scholar
• Ama Moor VJ, Pieme CA, Chetcha Chemegne B, et al. Oxidative profile of sickle cell patients in a Cameroonian urban hospital. BMC Clin Pathol. 2016;16:280. doi: 10.1186/s12907-016-0037-5
   Web of Science ®Google Scholar
• Jain SK, Shohet SB. A novel phospholipid in irreversibly sickled cells: evidence for in vivo peroxidative membrane damage in sickle cell disease. Blood. 1984;63:362–367.
   PubMed Web of Science ®Google Scholar
• Zhang D, Xu C, Manwani D, et al. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood. 2016;127:801–809. doi: 10.1182/blood-2015-09-618538
   PubMed Web of Science ®Google Scholar
• Bandeira IC, Rocha LB, Barbosa MC, et al. Chronic inflammatory state in sickle cell anemia patients is associated with HBB*S haplotype. Cytokine. 2014;65:217–221. doi: 10.1016/j.cyto.2013.10.009
   PubMed Web of Science ®Google Scholar
• Qari MH, Dier U, Mousa SA. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease. Clin Appl Thromb Hemost. 2012;18:195–200. doi: 10.1177/1076029611420992
   PubMed Web of Science ®Google Scholar
• Sarray S, Saleh LR, Lisa Saldanha F, et al. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. Cytokine. 2015;72:43–47. doi: 10.1016/j.cyto.2014.11.030
   PubMed Web of Science ®Google Scholar
• Steiner LA, Gallagher PG. Erythrocyte disorders in the perinatal period. Semin Perinatol. 2007;31:254–261. doi: 10.1053/j.semperi.2007.05.003
   PubMed Web of Science ®Google Scholar
• Kumar P, Raman T, Swain MM, et al. Hyperglycemia-induced oxidative-nitrosative stress induces inflammation and neurodegeneration via augmented tuberous sclerosis complex-2 (TSC-2) activation in neuronal cells. Mol Neurobiol. 2017;54:238–254. doi: 10.1007/s12035-015-9667-3
   PubMed Web of Science ®Google Scholar
• Kapoor R, Kakkar P. Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes. PLoS One. 2012;7:e41663. doi: 10.1371/journal.pone.0041663
   PubMed Web of Science ®Google Scholar
• Tsikas D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res. 2005;39:797–815. doi: 10.1080/10715760500053651
   PubMed Web of Science ®Google Scholar
• Sagar S, Kumar P, Behera RR, et al. Effects of CEES and LPS synergistically stimulate oxidative stress inactivates OGG1 signaling in macrophage cells. J Hazard Mater. 2014;278:236–249. doi: 10.1016/j.jhazmat.2014.05.096
   PubMed Web of Science ®Google Scholar
• Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol. 1994;233:380–385. doi: 10.1016/S0076-6879(94)33044-1
   PubMed Web of Science ®Google Scholar
• Das SK, Nair RC. Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br J Haematol. 1980;44:87–92. doi: 10.1111/j.1365-2141.1980.tb01186.x
   PubMed Web of Science ®Google Scholar
• Beretta L, Gerli GC, Ferraresi R, et al. Antioxidant system in sickle red cells. Acta Haematol. 1983;70:194–197. doi: 10.1159/000206722
   PubMed Web of Science ®Google Scholar
• Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends Pharmacol Sci. 2006;27:204–210. doi: 10.1016/j.tips.2006.02.007
   PubMed Web of Science ®Google Scholar
• Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376:2018–2031. doi: 10.1016/S0140-6736(10)61029-X
   PubMed Web of Science ®Google Scholar
• Silva DG, Belini Junior E, Torres Lde S, et al. Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia. Blood Cells Mol Dis. 2011;47:23–28. doi: 10.1016/j.bcmd.2011.03.004
   PubMed Web of Science ®Google Scholar
• Reid M, Badaloo A, Forrester T, et al. In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease. Am J Physiol Endocrinol Metab. 2006;291:E73–E79. doi: 10.1152/ajpendo.00287.2005
   PubMed Web of Science ®Google Scholar
• Morris CR, Suh JH, Hagar W, et al. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood. 2008;111:402–410. doi: 10.1182/blood-2007-04-081703
   PubMed Web of Science ®Google Scholar
• Hebbel RP. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood. 1991;77:214–237.
   PubMed Web of Science ®Google Scholar
• Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life. 2012;64:72–80. doi: 10.1002/iub.584
   PubMed Web of Science ®Google Scholar
• Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;4:89–96.
   PubMedGoogle Scholar
• Hebbel RP. Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain. Hematol Oncol Clin North Am. 2014;28:181–198. doi: 10.1016/j.hoc.2013.11.005
   PubMed Web of Science ®Google Scholar
• Hoppe CC. Inflammatory mediators of endothelial injury in sickle cell disease. Hematol Oncol Clin North Am. 2014;28:265–286. doi: 10.1016/j.hoc.2013.11.006
   PubMed Web of Science ®Google Scholar
• Lanaro C, Franco-Penteado CF, Albuqueque DM, et al. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leukoc Biol. 2009;85:235–242. doi: 10.1189/jlb.0708445
   PubMed Web of Science ®Google Scholar
• Conran N, Franco-Penteado CF, Costa FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin. 2009;33:1–16. doi: 10.1080/03630260802625709
   PubMed Web of Science ®Google Scholar